Aldosterone-producing adrenocortical carcinoma comprises less than 7% of all functioning adrenocortical carcinomas. We report a rare case of adrenocortical carcinoma with a clinical picture of primary aldosteronism and subclinical Cushing's syndrome and feminization. Complete surgical resection normalized blood pressures and aldosterone, cortisol and estradiol levels. Long-term monitoring is recommended with imaging and hormonal evaluation used as tumor markers for recurrence.
This report concerns a 71-year-old female with long standing untreated toxic multinodular goiter (TMG) coexisting with anaplastic thyroid carcinoma who presented with progressive shortness of breath and easy fatigability. Thyroid function tests showed suppressed TSH and elevated FT4 and FT3. Anti-thyroid hormone drugs were started. Thyrotropin receptor antibody was negative. A thyroid scan revealed both hot and cold nodules and fine needle aspiration biopsy (FNAB) of the thyroid gland showed colloid nodule. Chest CT scan imaging revealed an enlarged thyroid gland with the right lobe compressing the trachea. Patient underwent total thyroidectomy, final histopathology showed Anaplastic thyroid carcinoma. Our case is interesting from a pathophysiologic perspective,since it suggests that TMG can potentially transform into an aggressive form of thyroid carcinoma. High index of suspicion in patients with TMG with other risk factors for malignancy requires careful evaluation to detect cancer.
Objectives. The general objective was to compare the efficacy and safety of the Markovitz insulin protocol (MIP) with physician directed insulin infusion (PDI). Specific objectives were to compare the rate of change to normal glucose levels between MIP and PDP, time to achieve normal glucose levels and to determine the number of hypoglycemic episodes between MIP and PDI.Methodology. This is a retrospective study examining the medical records of critically ill patients admitted from 2001-2009. Efficacy outcome was measured as the time to achieve normal glucose level and the mean difference of percentage change towards normal blood glucose level. Safety outcome was measured in terms of frequency of hypoglycemic episodes.Results. One hundred and one patients met the inclusion criteria. The mean time required to achieve target blood glucose levels was 24 hrs (SD=19.5) for MIP compared to PDI. The mean drop in blood glucose levels was -235.49 (SD=113.4), with mean percent difference of -57.5% (SD=20.72) (p-value = 0.919) for MIP compared to physician directed. The MIP resulted in a higher percentage of blood glucose within target (19.57% vs 9.86 %) compared to PID (p= 0.005). Patients in MIP had shorter ICU stay (p=0.049). In addition, MIP was associated with a significantly lower rate of hypoglycemia at 4.2%, compared to PID at 30% (p<0.001).Conclusions. Markovitz insulin protocol appeared to be significant to physician directed insulin infusion in terms of its greater percentage of glucose measurements maintained within target range, without an increased risk of severe hypoglycemia.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.